Solid phase HLA antibody detection technology - Challenges in interpretation

Tissue Antigens

Volumn 76, Issue 2, 2010, Pages 87-95

  Tait, B D ^a   Hudson, F ^a   Brewin, G ^a   Cantwell, L ^a   Holdsworth, R ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

clinical outcome; complement binding and non complement binding HLA antibodies; enzyme linked immunosorbent assay (ELISA); HLA antibody detection; HLA class 1 antibodies; HLA class 2 antibodies; IgG and IgM antibodies; Luminex; naturally occurring HLA antibodies; renal transplantation

Indexed keywords

FLUORESCENT DYE; HLA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALGORITHM; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; COMPLEMENT FIXATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; GRAFT RECIPIENT; GRAFT REJECTION; HEAVY CHAIN; HUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEROLOGY; SOLID PHASE EXTRACTION;

BETA 2-MICROGLOBULIN; COMPLEMENT SYSTEM PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; IMMUNOASSAY; IMMUNOGLOBULIN M; ISOANTIBODIES; TRANSPLANTATION IMMUNOLOGY;

EID: 77954323369     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01486.x     Document Type: Review

References (66)

1. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotxins. Nature 1964 : 204 : 998 1000.
2. Kao KJ, Scornik JC, Small JC. Enzyme linked immunoassay for anti-HLA antibodies-an alternative to panel studies by lymphocytotoxicity. Transplantation 1993 : 55 : 192 196.
3. Worthington JE, Robson AJ, Sheldon S, Langton A, Martin S. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum Immunol 2001 : 62 : 1178 1184.
4. Monien S, Salama A, Schonemann C. ELISA methods detect HLA antibodies with variable sensitivity. Int J Immunogenet 2006 : 33 : 163 166.
5. Rebibou JM, Chabod J, Bittencourt MC et al. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transpl Immunol 2000 : 8 : 125 128.
6. Colombo MB, Haworth SE, Poli F et al. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom 2007 : 72 : 465 471.
7. Pretl K, Chesterton KA, Scholander JT, Leffell MS, Zachary AA. Accurate rapid characterisation of HLA specific antibodies using Luminex technology. Human Immunol 2003 : 64 (Suppl 1) : pS108.
8. Phelan D, Pang S, Phelan C, Grant G, Land G. When is sensitive too sensitive? Human Immunol 2007 : 68 (Suppl 1): 27.
9. Saidman SL. Histocompatibility testing for highly sensitised transplant candidates. Transplant Proc 2007 : 39 : 673 675.
10. Leffell MS. Montgomery RA, Zachary AA. The changing role of antibody testing in transplantation. In: Cecka JM, Terasaki PI eds. Clinical Transplants 2005 Terasaki Foundation Laboratory
11. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: sensitivity, specificity and clinical significance in solid organ transplantation. Immunol Res 2006 : 36 : 255 264.
12. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC. Detection of donor specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006 : 21 : 2625 2629.
13. Smith JD, Hamour IM, Banner NR, Rose ML. C4d fixing Luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007 : 7 : 2809 2815.
14. Castillo-Rama M, Castro MJ, Bernardo I et al. Pre-formed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl 2008 : 14 : 554 562.
15. Van Den Berg-Loonen EM, Billen EVA, Voorter CEM et al. Clinical relevance of pre transplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008 : 85 : 1086 1090.
16. Bielmann D, Honger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S. Pre transplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007 : 7 : 626 632.
17. Lefaucheur C, Suberbielle-Boisel C, Hill GS et al. Clinical relevance of preformed HLA donor-specific antibodies in clinical transplantation. Am J Trans 2008 : 8 : 324 331.
18. Wahrmann M, Bartel G, Exner M et al. Clinical relevance of preformed C4d-fixing and non-C4d fixing HLA single antigen reactivity in renal allograft recipients. Transplant Int 2009 : 22 : 982 989.
19. Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal transplant patients. Transplantation 2003 : 76 : 1519 1525.
20. Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: a single centre's perspective. Paediatr Transplant 2004 : 8 : 535 542.
21. Jordan SC, Locke JE, Montgomery RA. De-sensitization protocols for crossing leukocyte antigen and ABO incompatible barrier. Curr Opin Organ Transplant 2007 : 12 : 371 378.
22. Lefaucheur C, Nochy D, Andrade J et al. Comparison of combination plasmapheresis/IVIG/Anti-CD20 versus high-dose IVIG in the treatment of antibody-mediated rejection. Am J Transplant 2009: 9 : 1099 1107.
23. Jordan SC, Peng A, Vo AA. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. Contrib Nephrol 2009 : 162 : 13 26.
24. Chopek MW, Simmons RL, Platt JL. ABO incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc 1987 : 19 : 4553 4557.
25. Park WD, Grande JP, Ninova D et al. Accommodation in ABO-incompatible kidney allografts,a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003 : 3 : 952 960.
26. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exhange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003 : 9 : 22 31.
27. Atz ME, Reed EF. Role of anti-MHC class 1 antibody in facilitating transplant accommodation. Crit Rev Immunol 2008 : 28 : 485 511.
28. Turgeon NA, Kirk AD, Iwakoshi NN. Differential effect of donor-specific alloantibody. Transpl Rev 2009 : 23 : 25 32.
29. Duquesnoy RJ, Marrari M. Correlations between Terasaki's HLA class 1 epitopes and HLAMatchmaker defined eplets on HLA-A,-B and C antigens. Tissue Antigens 2009 : 74 : 117 133.
30. Mararri M, Duquesnoy RJ. Correlations between Terasaki's HLA class 2 epitopes and HLAMatchmaker defined eplets on HLA-DR and -DQ antigens. Tissue Antigens 2009 : 74 : 134 146.
31. El-Awar NR, Akaza T, Terasaki PI, Nguyen A. Human leukocyte antigen class 1 epitopes: update to 103 total epitopes including the C locus. Transplantation 2007 : 84 : 532 540.
32. El-Awar N, Terasaki PI, Cai J, Deng CT, Ozawa M, Nguyen A. Epitopes of the HLA-A,B,C,DR,DQ and MICA antigens. In: Cecka JM, Tersaki PI eds. Clinical Transplants 2007; Publisher Terasaki Foundation Laboratory
33. Claas FH, Doxiadis II. Management of the highly sensitized patient. Curr Opin Immunol 2009 : 21 : 569 572.
34. Duquesnoy R. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008 : 20 : 594 601.
35. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. 1. Description of the algorithm. Hum Immunol 2002 : 63 : 339 352.
36. Blair S, Tait B, Hudson F, Kannellis J. Acute humoral rejection associated with HLA-DOB1 antibody in an HLA identical (A, B, DR, DQ) recipient [Abstract]. Transplantation Society of Australia and New Zealand Annual Scientific Meeting, Canberra, Australia, April 2007.
37. Qiu J, Cai J, Terasaki PI, El-Awar N, Lee J-H. Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. Transplantation 2005 : 80 : 1511 1513.
38. Deng CT, Cai J, Tarsitani C, El-Awar N, Lachmann N, Ozawa M. HLA class 2 DQ epitopes. In: Terasaki PI ed. Clinical transplants 2006; Publisher Terasaki Foundation Laboratory
39. Proust B, Kennel A, Ladriere M, Kissler M, Perrier P. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Transpl Immunol 2009 : 21 : 166 168.
40. Deng CT, El-Awar N, Ozawa M, Cai J, Lachmann N, Terasaki PI. Human leukocyte antigen class 2 DQ alpha and beta epitopes identified from sera of kidney allograft recipients. Transplantation 2008 : 86 : 452 9.
41. Zeevi A, Lunz JG, Shapiro R et al. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009 : 70 : 645 650.
42. Piazza A, Poggi E, Ozzella G et al. Anti-DP antibodies and graft failure Abstract 520. The First Joint International Transplant Meeting, Boston, Massachusetts, July 2006.
43. Rosen-Bronsen S. A*0301 specific HLA antibody detected in the serum of an A*0302 positive renal transplant recipient. One Lambda Advanced LABMAS Workshop, Los Angeles, 14 17 August 2007.
44. Pancoska C, Breed R, Harris P, Sonuga B, Venzon I. Emergent PRA technologies may detect unexpected antibodies in the sera of solid organ transplant recipients. One Lambda Advanced LABMAS Workshop, Los Angeles, 14-17 August 2007.
45. Mizutani K, Terasaki PI, Shih RNJ, Pei R, Ozawa M, Lee J. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 2006 : 67 : 223 229.
46. Mizutani K, Terasaki PI, Bignon JD et al. Association of kidney transplant failure and antibodies against MICA. Hum Immunol 2006 : 67 : 683 691.
47. Amezaga N, Crespo M, Lopez-Cobos M et al. Relevance of MICA antibodies in acute humoral rejection in renal transplant patients. Transplant Immunol 2006 : 17 : 39 42.
48. Panigrahi A, Gupta N, Siddiqui JA et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol 2007 : 68 : 362 367.
49. Zou Y, Stastny P, Susal C, Dohler B, Opelz G. Antibodies against MICA antigens and kidney transplant rejection. NEJM 2007 : 357 : 1293 1300.
50. Alvarez-Marquez A, Aquilera I, Gentil MA et al. Donor specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Transplantation 2009 : 87 : 94 99.
51. Suarez-Alvarez B, Alonso-Arias R, Bravo-Mendoza C et al. Identification of epitopes and immunodominant regions on the MICA protein defined by alloantibodies from kidney transplant patients. Transplantation 2009 : 88 (Suppl 3): S68 77.
52. Billen EVA, Christiaans MHL, Van Den Berg-Loonen EM. Clinical relevance of Luminex donor specific crossmatches:data from 165 renal transplants. Tissue Antigens 2009 : 74 : 205 212.
53. Heinemann FM, Roth I, Rebmann V et al. Immunoglobulin isotype-specific characterisation of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum Immunol 2007: 68 : 500 506.
54. Arnold M-L, Dechant M, Doxiadis IIN, Spriewald BM. Prevalence and specificity of immunoglobulin G and immunoblobulin A non-complement binding anti-HLA alloantibodies in renal transplant candidates. Tissue Antigens 2008 : 72 : 60 6.
55. Bartel G, Wahrmann M, Exner M et al. Determinants of the complement fixing ability of recipient pre-sensitization against HLA antigens. Transplantation 2007 : 83 : 727 733.
56. Kozakowski N, Regele H. Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function. Transpl Int 2009 : 22 : 945 953.
57. Dragun D. Humoral responses directed against non-human leukocyte antigens in solid organ transplantation. Transplantation 2008 : 86 : 1019 1025.
58. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Successful renal transplantation in the presence of donor specific HLA IgM antibodies. Transplant Proc 1992 : 27 : 664.
59. Tardif GN, McCalmon RT. Successful renal transplantation in the presence of donor specific HLA IgM antibodies. Transplant Proc 1995 : 27 : 664 665.
60. Suzuki M, Ishida H, Komatsu T, Kennoki T, Ishizuka T, Tanabe K. Kidney transplantation in a recipient with anti-HLA antibody IgM positive. Transpl Immunol 2009 : 21 : 150 154.
61. Stastny P, Ring S, Lu C, Arenas J, Han M, Lavingia B. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol 2009 : 70 : 600 604.
62. Zachary AA, Lucas DP, Detrick B, Leffell MS. Naturally occurring interference in Luminex assays for HLA specific antibodies: characteristics and resolution. Hum Immunol 2009 : 70 : 496 501.
63. Cai J, Terasaki PI. A comparison of reactions of single antigen cell lines with reactions produced by single antigen beads. Presented at the International HLA and Transplantation Conference, Los Angeles, CA, 31 January to 1 February, 2004.
64. Cai J, Terasaki PI, Anderson N, Lachmann N, Schonemann C. Intact HLA not β-2-m free heavy chain- specific HLA class 1 antibodies are predictive of graft failure. Transplantation 2009 : 88 : 226 230.
65. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee J-H, El-Awar N, Alberu J. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008 : 86 : 1111 1115.
66. El-Awar N, Terasaki PI, Nguyen A et al. Epitopes of human leukocyte antigen class 1 antibodies found in sera of normal healthy males and cord blood. Hum Immunol 2009 : 70 : 844 853.